Trial Profile
Phase II trial evaluating fotemustine (Muphoran) treatment in patients with refractory or relapsing multiple myeloma.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Fotemustine (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 13 Jul 2011 New trial record